McKesson closes fiscal year on the upswing

Saying it delivered a "solid financial performance," McKesson Corp. released its results for its fiscal year ending March 31.

Revenues reached $69.5 billion, an increase of 22 percent over $57.1 billion in the previous fiscal year. Net income rose to $646.5 million, up 16 percent from $555.4 million in the last fiscal year.

McKesson Chairman and CEO John H. Hammergren described revenue growth in the company's Information Solutions business unit for the fiscal year as "modest." He continued that "Software revenues were impacted by slower demand for non-clinical software and longer installation periods needed to implement our complex clinical contracts."

Hammergren added that McKesson's long-term growth potential "remains extremely positive."

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup